Matt Biegler's Stock Ratings

Oppenheimer Analyst

Matt Biegler is an analyst at Oppenheimer. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/15/2025

Updated: Dec 15, 2025

Overall Average Return

-60.3%

Smart Score

8.64%

Overall Average Return Percentile

2nd

Number of Ratings

3
Buy NowGet Alert
03/11/2025OKURBuy Now
OnKure Therapeutics
$3.11863.76%$35 → $30MaintainsOutperformGet Alert
11/08/2024ALLOBuy Now
Allogene Therapeutics
$1.53552.06%$11 → $10MaintainsOutperformGet Alert
10/10/2024OKURBuy Now
OnKure Therapeutics
$3.111024.39% → $35Initiates → OutperformGet Alert